The UK has approved a second experimental COVID-19 vaccine for use on its population. Oxford Astrazeneca’s offering alleges to be 62 – 90% effective and everyone needs to just forget about the transverse myelitis issue which came out of the trials, I’m sure it wasn’t connected to the vaccine……
Yes, I know – how unprofessional of me, slipping some negative opinion into the opening statement. Well hang me now, I do so, because no one else wants to talk about it. Transverse Myelitus is pretty serious and can affect those affected for life.
Transverse myelitis interrupts the messages that the spinal cord nerves send throughout the body. This can cause pain, muscle weakness, paralysis, sensory problems, or bladder and bowel dysfunction.
There are many different causes of transverse myelitis, including infections and immune system disorders that attack the body’s tissues. It could also be caused by other myelin disorders, such as multiple sclerosis. Other conditions, such as a stroke of the spinal cord, are often confused with transverse myelitis, and these conditions require different treatment approaches.
Treatment for transverse myelitis includes medications and rehabilitative therapy. Most people with transverse myelitis recover, at least partially. Those with severe attacks sometimes are left with major disabilities. – Mayo Clinic
It is true, the incidence of this life-changing illness may have had nothing to do with the vaccine, but is it worth the risk at this early stage?
Health Secretary Matt Hancock said the rollout will start on 4 January “and will really accelerate into the first few weeks of next year”.
The UK has ordered 100 million doses from the manufacturer AstraZeneca – enough to vaccinate 50 million people.
The approval, by the medicines regulator, means the vaccine is both safe and effective. – BBC News
The BBC once again making stuff up of course, the medicines regulator approving the vaccine for emergency use does not mean it is ‘Safe & Effective’. It means that they have made a ‘Relative Risk’ assessment.
Let us know what you think about this latest vaccine ready to hit the population in the comments below.